IRadimed Corporation (IRMD) 当前追踪市盈率 (P/E) 为 55.0, 前瞻市盈率为 46.1. 追踪盈利收益率为 1.82%, 前瞻盈利收益率 2.17%. PEG 3.29. 格雷厄姆数为 $17.17.
本页证实的标准:
SharesGrow 综合评分： 79/100 其中 5/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | 16.6 | -11.32 | 3.77 | 3.70 | - |
| 2017 | 322.5 | -3.49 | 4.89 | 6.98 | - |
| 2018 | 47.0 | 0.05 | 7.06 | 9.73 | - |
| 2019 | 27.4 | 0.43 | 4.75 | 6.85 | - |
| 2020 | 201.9 | -2.32 | 4.50 | 8.72 | - |
| 2021 | 61.2 | 0.10 | 7.90 | 13.64 | - |
| 2022 | 27.7 | 0.81 | 4.82 | 6.67 | 3.53% |
| 2023 | 34.8 | 1.04 | 8.38 | 9.13 | 2.21% |
| 2024 | 36.2 | 3.08 | 8.03 | 9.51 | 1.96% |
| 2025 | 55.1 | 3.35 | 13.08 | 14.77 | 1.22% |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $0.60 | $32.5M | $7.21M | 22.2% |
| 2017 | $0.04 | $23.08M | $499.76K | 2.2% |
| 2018 | $0.52 | $30.44M | $6.3M | 20.7% |
| 2019 | $0.78 | $38.52M | $9.63M | 25% |
| 2020 | $0.11 | $31.72M | $1.37M | 4.3% |
| 2021 | $0.74 | $41.81M | $9.33M | 22.3% |
| 2022 | $1.02 | $53.3M | $12.83M | 24.1% |
| 2023 | $1.35 | $65.56M | $17.19M | 26.2% |
| 2024 | $1.50 | $73.24M | $19.23M | 26.3% |
| 2025 | $1.75 | $83.81M | $22.48M | 26.8% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $2.08 | $2.05 – $2.11 | $91.92M | $90.96M – $92.87M | 2 |
| 2027 | $2.32 | $2.29 – $2.35 | $101.14M | $100.08M – $102.18M | 2 |
| 2028 | $2.67 | $2.63 – $2.71 | $121.1M | $119.84M – $122.35M | 1 |
| 2029 | $3.04 | $3.00 – $3.08 | $131.9M | $130.52M – $133.26M | 1 |
| 2030 | $3.43 | $3.38 – $3.48 | $145.9M | $144.38M – $147.41M | 1 |
